Comparison between LigaSure™ and Harmonic® in Laparoscopic Sleeve Gastrectomy: A Single-Center Experience on 422 Patients.
Journal
Journal of obesity
ISSN: 2090-0716
Titre abrégé: J Obes
Pays: United States
ID NLM: 101526295
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
10
2018
revised:
26
11
2018
accepted:
09
12
2018
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
11
8
2020
Statut:
epublish
Résumé
New laparoscopic devices, such as electrothermal bipolar-activated devices (LigaSure™ (LS)) or ultrasonic systems (Harmonic® scalpel (HS)), have been applied recently to bariatric surgery allowing to reduce blood loss and surgical risks. The aim of this study was to retrospectively compare intraoperative performance of HS and LS, postoperative results, and clinical outcomes in a large cohort of patients undergoing LSG. Data from 422 morbidly obese patients undergoing LSG in our Bariatric Unit at the Advanced Biomedical Sciences Department of the "Federico II" University of Naples (Italy) between January 2009 and December 2017 were retrospectively analyzed. Subjects were divided into two groups (HS and LS), and operative time, intraoperative complications, and postoperative (within 30 days from surgery) complications were compared. Bleeding from the omentum or from the staple line, use of hemostatic clips, and absorbable hemostat were recorded as intraoperative complications; hemorrhages, abscess formation, gastric leaks, fever, and mortality were considered as postoperative complications. Statistical analysis showed no difference in terms of baseline demographics between the two cohorts. Operative time (48 ± 9 vs 49 ± 6 min, Harmonic® and LigaSure™ are both useful tools in bariatric surgery, and these two advanced power devices are user-friendly and can facilitate surgeon work; from this point of view, the choice of the energy device should be based on the preference of the surgeon and on the hospital costs policy and availability.
Sections du résumé
Background
New laparoscopic devices, such as electrothermal bipolar-activated devices (LigaSure™ (LS)) or ultrasonic systems (Harmonic® scalpel (HS)), have been applied recently to bariatric surgery allowing to reduce blood loss and surgical risks. The aim of this study was to retrospectively compare intraoperative performance of HS and LS, postoperative results, and clinical outcomes in a large cohort of patients undergoing LSG.
Methods
Data from 422 morbidly obese patients undergoing LSG in our Bariatric Unit at the Advanced Biomedical Sciences Department of the "Federico II" University of Naples (Italy) between January 2009 and December 2017 were retrospectively analyzed. Subjects were divided into two groups (HS and LS), and operative time, intraoperative complications, and postoperative (within 30 days from surgery) complications were compared. Bleeding from the omentum or from the staple line, use of hemostatic clips, and absorbable hemostat were recorded as intraoperative complications; hemorrhages, abscess formation, gastric leaks, fever, and mortality were considered as postoperative complications.
Results
Statistical analysis showed no difference in terms of baseline demographics between the two cohorts. Operative time (48 ± 9 vs 49 ± 6 min,
Conclusion
Harmonic® and LigaSure™ are both useful tools in bariatric surgery, and these two advanced power devices are user-friendly and can facilitate surgeon work; from this point of view, the choice of the energy device should be based on the preference of the surgeon and on the hospital costs policy and availability.
Identifiants
pubmed: 30719344
doi: 10.1155/2019/3402137
pmc: PMC6335858
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3402137Références
Ann Chir. 2000 Jun;125(5):468-72
pubmed: 10925490
Obes Surg. 2003 Aug;13(4):649-54
pubmed: 12935370
Obes Surg. 2003 Dec;13(6):861-4
pubmed: 14738671
Obes Surg. 2004 Nov-Dec;14(10):1290-8
pubmed: 15603641
Surg Endosc. 2007 Sep;21(9):1526-31
pubmed: 17287913
HPB (Oxford). 2008;10(4):253-5
pubmed: 18773105
Dis Colon Rectum. 2009 Apr;52(4):657-61
pubmed: 19404071
Ann Ital Chir. 2011 Jul-Aug;82(4):273-7
pubmed: 21834476
Ann Surg. 2011 Sep;254(3):410-20; discussion 420-2
pubmed: 21865942
Eur J Clin Nutr. 2012 May;66(5):645-7
pubmed: 22318651
Curr Drug Targets. 2013 Jul;14(8):880-8
pubmed: 23627916
Eur Eat Disord Rev. 2014 Jul;22(4):223-9
pubmed: 24764323
Int J Surg. 2014;12 Suppl 1:S183-8
pubmed: 24861545
Surg Obes Relat Dis. 2014 Jul-Aug;10(4):607-11
pubmed: 24935179
Updates Surg. 2014 Sep;66(3):197-201
pubmed: 24961471
Med Devices (Auckl). 2014 Jul 30;7:263-71
pubmed: 25114600
Int J Surg. 2014;12 Suppl 2:S69-S72
pubmed: 25159229
ANZ J Surg. 2017 Apr;87(4):252-256
pubmed: 25214362
Obes Surg. 2015 Aug;25(8):1454-7
pubmed: 25543323
World J Gastrointest Endosc. 2015 Jul 25;7(9):843-6
pubmed: 26240685
Obes Surg. 2016 Feb;26(2):443-51
pubmed: 26661108
Int J Surg. 2016 Apr;28 Suppl 1:S124-7
pubmed: 26708855
J Laparoendosc Adv Surg Tech A. 2016 Dec;26(12):950-953
pubmed: 27120107
J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S166
pubmed: 27678920
Obes Surg. 2017 Aug;27(8):2106-2112
pubmed: 28233264
Head Neck. 2017 Jun;39(6):1078-1085
pubmed: 28346729
Wideochir Inne Tech Maloinwazyjne. 2017;12(1):28-31
pubmed: 28446929
J Chin Med Assoc. 2018 Feb;81(2):178-182
pubmed: 29129517
Am J Emerg Med. 2018 Mar;36(3):475-479
pubmed: 29306650
Obes Surg. 2018 Mar;28(3):852-853
pubmed: 29307105
J Endourol. 2018 Apr;32(4):329-337
pubmed: 29463122
Obes Surg. 2018 Aug;28(8):2396-2405
pubmed: 29516397
J Endocrinol Invest. 2018 Nov;41(11):1307-1315
pubmed: 29574529
Med Sci Monit. 2018 Apr 12;24:2173-2179
pubmed: 29643327
Obes Surg. 2018 Nov;28(11):3604-3610
pubmed: 30019280